» Articles » PMID: 35279135

The Interaction Between Nanoparticles and Immune System: Application in the Treatment of Inflammatory Diseases

Overview
Publisher Biomed Central
Specialty Biotechnology
Date 2022 Mar 13
PMID 35279135
Authors
Affiliations
Soon will be listed here.
Abstract

Nanoparticle (NP) is an emerging tool applied in the biomedical field. With combination of different materials and adjustment of their physical and chemical properties, nanoparticles can have diverse effects on the organism and may change the treating paradigm of multiple diseases in the future. More and more results show that nanoparticles can function as immunomodulators and some formulas have been approved for the treatment of inflammation-related diseases. However, our current understanding of the mechanisms that nanoparticles can influence immune responses is still limited, and systemic clinical trials are necessary for the evaluation of their security and long-term effects. This review provides an overview of the recent advances in nanoparticles that can interact with different cellular and molecular components of the immune system and their application in the management of inflammatory diseases, which are caused by abnormal immune reactions. This article focuses on the mechanisms of interaction between nanoparticles and the immune system and tries to provide a reference for the future design of nanotechnology for the treatment of inflammatory diseases.

Citing Articles

A Comprehensive Review of Nanoparticle-Based Drug Delivery for Modulating PI3K/AKT/mTOR-Mediated Autophagy in Cancer.

Rahman M, Jalouli M, Bhajan S, Al-Zharani M, Harrath A Int J Mol Sci. 2025; 26(5).

PMID: 40076496 PMC: 11899884. DOI: 10.3390/ijms26051868.


Engineered Shape-Tunable Copper-Coordinated Nanoparticles for Macrophage Reprogramming.

Gao H, Cheng R, Cardoso I, Lobita M, Pacheco-Fernandez I, Bartolo R Nano Lett. 2025; 25(7):2831-2840.

PMID: 39914892 PMC: 11849021. DOI: 10.1021/acs.nanolett.4c05999.


Biodegradable and Stimuli-Responsive Nanomaterials for Targeted Drug Delivery in Autoimmune Diseases.

Parvin N, Joo S, Mandal T J Funct Biomater. 2025; 16(1).

PMID: 39852580 PMC: 11766201. DOI: 10.3390/jfb16010024.


Activation of Immune Responses Through the RIG-I Pathway Using TRITC-Dextran Encapsulated Nanoparticles.

Baek H, Yang S, Kim M, Kim D, Lee C, Kim S Immune Netw. 2025; 24(6):e44.

PMID: 39801741 PMC: 11711124. DOI: 10.4110/in.2024.24.e44.


Regulation of dynamic spatiotemporal inflammation by nanomaterials in spinal cord injury.

Liu Z, Xiang C, Zhao X, Aizawa T, Niu R, Zhao J J Nanobiotechnology. 2024; 22(1):767.

PMID: 39696584 PMC: 11657436. DOI: 10.1186/s12951-024-03037-8.


References
1.
Aratani Y . Myeloperoxidase: Its role for host defense, inflammation, and neutrophil function. Arch Biochem Biophys. 2018; 640:47-52. DOI: 10.1016/j.abb.2018.01.004. View

2.
Ginhoux F, Guilliams M . Tissue-Resident Macrophage Ontogeny and Homeostasis. Immunity. 2016; 44(3):439-449. DOI: 10.1016/j.immuni.2016.02.024. View

3.
Heidt T, Sager H, Courties G, Dutta P, Iwamoto Y, Zaltsman A . Chronic variable stress activates hematopoietic stem cells. Nat Med. 2014; 20(7):754-758. PMC: 4087061. DOI: 10.1038/nm.3589. View

4.
Mitchell M, Billingsley M, Haley R, Wechsler M, Peppas N, Langer R . Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2020; 20(2):101-124. PMC: 7717100. DOI: 10.1038/s41573-020-0090-8. View

5.
Carnasciali A, Amoriello R, Bonechi E, Mazzoni A, Ravagli C, Doumett S . T Cell Delivery of Nanoparticles-Bound Anti-CD20 Monoclonal Antibody: Successful B Cell Depletion in the Spinal Cord during Experimental Autoimmune Encephalomyelitis. J Neuroimmune Pharmacol. 2020; 16(2):376-389. DOI: 10.1007/s11481-020-09931-w. View